Endosonography-guided real-time fine-needle aspiration biopsy

1994 ◽  
Vol 40 (6) ◽  
pp. 700-707 ◽  
Author(s):  
Maurits J. Wiersema ◽  
Michael L. Kochman ◽  
Harvey M. Cramer ◽  
Liang C. Tao ◽  
Lisa M. Wiersema
1997 ◽  
Vol 15 (4) ◽  
pp. 1439-1443 ◽  
Author(s):  
D O Faigel ◽  
G G Ginsberg ◽  
J S Bentz ◽  
P K Gupta ◽  
D B Smith ◽  
...  

BACKGROUND Endoscopic ultrasound (EUS) is an important new tool in the staging of pancreatic malignancies. Using new curved linear-array instruments, real-time fine-needle aspiration biopsy (RTFNA) of pancreatic lesions can be performed. METHODS Forty-five patients with pancreatic lesions (22 males and 23 females) underwent staging with the Olympus EUM-20 (Olympus America Corp, Melville, NY) followed by EUS-RTFNA with the Pentax FG-32PUA (Pentax-Precision Instrument Corp, Orangeburg, NY) and the 22-gauge GIP needle (GIP Medizin Technik, Grassau, Germany). RESULTS EUS tumor stages were as follows: TO, n = 1; T1, n = 8; T2, n = 9; and T3 n = 27. Aspiration attempts were unsuccessful in four patients (two technical failures and two inadequate specimens). The remaining 41 lesions (mean size, 3.3 cm) were aspirated under EUS guidance (median passes, three) and the cytologic diagnoses were 25 definite adenocarcinoma, five suspicious for adenocarcinoma (three subsequently confirmed and two clinical course consistent with adenocarcinoma), and 11 negative for malignancy. Of 11 negatives, two were found to have adenocarcinoma, seven were confirmed benign at surgery (four cystadenomas and three inflammatory), one had a benign pseudocyst, and one had abundant inflammatory cells on RTFNA and follow-up time greater than 12 months with computed tomographic (CT) scans consistent with resolving inflammation. There were no false-positive RTFNAs. There were no procedure-related complications. Among those with diagnostic EUS-RTFNA (91%), the sensitivity for malignancy (confirmed plus suspicious) was 94% and negative predictive value 82%. CONCLUSION EUS-guided RTFNA is a safe and accurate method for performing pancreatic biopsy. It should be considered in patients with suspected pancreatic malignancies in whom a tissue diagnosis is required or when other modalities have failed. EUS-RTFNA allows for local staging and tissue diagnosis in one procedure.


Author(s):  
G Q Khan ◽  
M Tanvir ◽  
M Iftikhar ◽  
M Y Bhat ◽  
G Mohiuddin ◽  
...  

DOI: http://dx.doi.org/10.5915/30-1-16283The utility of fine needle aspiration biopsy (FNAB) guided by real-time ultrasonography was studied in 25 patients referred with peripheral lung opacities on chest x-ray examination and in whom fiberoptic bronchoscopy was negative. The lesion, as seen on a chest x-ray, was visualized sonographically in 22 (88%) patients, and aspiration biopsy was performed in 20 of these 22 patients, two patients being excluded due to sonographic evidence of a hydatid cyst. Aspiration biopsy was diagnostic in 17 (85%) of the 20 patients studied including 12 patients with malignancy and five patients with benign lesion. One patient developed a small asymptomatic pneumothorax, detected on routine postprocedure chest x-ray examination. Thus fine needle aspiration biopsy underultrasonographic guidance is a safe, economical method with a high diagnosticyield in the evaluation of peripheral lung opacities, especially in developing countries where computed tomography scan facilities are limited and costly.


Sign in / Sign up

Export Citation Format

Share Document